Celecoxib has been evaluated in numerous clinical trials ranging from Phase 1 through Phase 4, with recruitment statuses encompassing completed, active, and recruiting studies. These investigations assess the agent across diverse indications, including knee osteoarthritis, postoperative pain, pediatric pharmacokinetics, major depressive disorder, and metastatic prostate cancer. Broadly sponsored by academic medical centers, hospital health systems, government agencies, and pharmaceutical companies, completed trials have evaluated outcomes such as the compound's effect on neuroinflammation in depression.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT03026140 | RECRUITING | Colon Carcinoma |
The Netherlands Cancer Institute |
2017-03-29 | PHASE2 |
| NCT06699966 | NOT_YET_RECRUITING | Major Depressive Disorder |
Stony Brook University |
2027-06 | PHASE4 |
| NCT06942039 | RECRUITING | CNS Embryonal Tumor; CNS, Medulloblastoma; Atypical Teratoid Rhabdoid Tumor; Medulloblastoma, Childhood; Medulloblastoma, Group 3; Medulloblastoma, Group 4; Pineoblastoma; Neuroblastoma; Embryonal Tumor With Multilayered Rosettes; Embryonal Tumor With Abundant Neuropil and True Rosettes; Ependymoblastoma; Medulloepithelioma; CNS Embryonal Tumor With Rhabdoid Features; CNS Embryonal Tumor, Nos |
C17 Council |
2025-09-23 | EARLY_PHASE1 |
| NCT03686657 | WITHDRAWN | Type 2 Diabetes; High Blood Pressure; Arthritis; Obesity |
ARKAY Therapeutics |
2026-12-10 | PHASE1; PHASE2 |
| NCT01356290 | RECRUITING | Medulloblastoma Recurrent; Ependymoma Recurrent; ATRT Recurrent; Rare CNS Tumor Recurrent |
Medical University of Vienna |
2014-04 | PHASE2 |
| NCT07632235 | NOT_YET_RECRUITING | Intrahepatic Cholangiocarcinoma (Icc) |
Shanghai 6th People's Hospital |
2026-09-15 | PHASE1; PHASE2 |
| NCT04469530 | RECRUITING | Solid Tumor |
Emory University |
2020-09-16 | PHASE2 |
| NCT06722534 | RECRUITING | Peutz-Jeghers Syndrome; Celecoxib; Small Bowel Polyp |
Air Force Military Medical University, China |
2025-02-01 | |
| NCT07104266 | RECRUITING | Triple-Negative Breast Cancer |
Université de Sherbrooke |
2025-08-04 | PHASE2 |
| NCT07154316 | RECRUITING | Colorectal Cancer |
Fudan University |
2025-08-01 | PHASE2 |
| NCT07634094 | NOT_YET_RECRUITING | Ovarian Cancer |
Kalinski, Pawel, MD, PhD |
2026-08 | PHASE2 |
| NCT04488081 | ACTIVE_NOT_RECRUITING | COVID-19 |
QuantumLeap Healthcare Collaborative |
2020-07-31 | PHASE2 |
| NCT04860635 | SUSPENDED | Analgesia |
Arthritis Innovation Corporation |
2027-01 | PHASE2; PHASE3 |
| NCT06997068 | RECRUITING | Metastatic Oral Cavity Carcinoma; Recurrent Oral Cavity Carcinoma; Stage IVC Lip and Oral Cavity Cancer AJCC v8; Head and Neck Cancer; Hypopharynx Cancer; Oropharynx Cancer; Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Metastatic Hypopharyngeal Carcinoma; Metastatic Laryngeal Carcinoma; Metastatic Malignant Head and Neck Neoplasm; Metastatic Oropharyngeal Carcinoma; Recurrent Hypopharyngeal Carcinoma; Recurrent Laryngeal Carcinoma; Recurrent Malignant Head and Neck Neoplasm; Recurrent Oropharyngeal Carcinoma; Stage IVC Hypopharyngeal Carcinoma AJCC v8; Stage IVC Laryngeal Cancer AJCC v8; Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 |
Mayo Clinic |
2025-07-09 | PHASE2 |
| NCT06903858 | RECRUITING | Colorectal Cancer; Microsatellite Instability High; Mismatch Repair Deficiency |
Sun Yat-sen University |
2025-06-01 | PHASE2 |
| NCT07494565 | RECRUITING | Diffuse Large B-Cell Lymphoma (DLBCL); CD5 Positive |
Sun Yat-sen University |
2026-03-06 | PHASE2 |
| NCT03590821 | NOT_YET_RECRUITING | Healthy |
University of Pennsylvania |
2027-12 | EARLY_PHASE1 |
| NCT07673549 | NOT_YET_RECRUITING | Idiopathic Trigeminal Neuralgia |
Beijing Tiantan Hospital |
2026-08-31 | |
| NCT02993029 | RECRUITING | Treatment Outcome |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2017-09-01 | |
| NCT07139405 | NOT_YET_RECRUITING | Type 2 Diabetes (T2DM) |
Myopharm Limited |
2026-09-01 | PHASE2 |
| NCT06505187 | RECRUITING | Parotidectomy |
University of Wisconsin, Madison |
2025-02-28 | PHASE2 |
| NCT07150949 | RECRUITING | Locally Advanced Rectal Cancer; Neoadjuvant Therapy |
Fudan University |
2025-08-28 | PHASE2 |
| NCT05434065 | RECRUITING | Intracerebral Hemorrhage |
National Taiwan University Hospital |
2023-01-01 | PHASE2 |
| NCT05343013 | RECRUITING | Colorectal Cancer |
M.D. Anderson Cancer Center |
2022-06-06 | PHASE2 |
| NCT03926338 | RECRUITING | Colorectal Cancer; Mismatch Repair-deficient (dMMR); Microsatellite Instability-high (MSI-H); Neoadjuvant Therapy |
Sun Yat-sen University |
2019-05-10 | PHASE2 |
| NCT04041050 | ACTIVE_NOT_RECRUITING | Myeloproliferative Neoplasm |
AbbVie |
2019-11-08 | PHASE1 |
| NCT05731726 | RECRUITING | pMMR; MSS; MSI-L; Locally Advanced Rectal Carcinoma |
Zhejiang University |
2023-02-22 | PHASE2 |
| NCT05637086 | RECRUITING | Epilepsy |
Mostafa Bahaa |
2022-12-20 | PHASE2 |
| NCT07246278 | RECRUITING | Parkinson Disease |
Tanta University |
2025-11-20 | PHASE1; PHASE2 |
| NCT06231758 | RECRUITING | Osteo Arthritis Knee |
Mostafa Bahaa |
2024-01-30 | PHASE3 |
| NCT07174570 | RECRUITING | Advanced Hepatocellular Carcinoma; Metastatic Hepatocellular Carcinoma; Stage III Hepatocellular Carcinoma AJCC v8; Stage IV Hepatocellular Carcinoma AJCC v8 |
Emory University |
2026-01-02 | PHASE2 |
| NCT05644301 | RECRUITING | Major Depressive Disorder; Inflammation |
Universiteit Antwerpen |
2023-09-21 | PHASE3 |
| NCT04786548 | SUSPENDED | Obsessive-Compulsive Disorder |
New York State Psychiatric Institute |
2021-04-01 | PHASE2 |
| NCT07351968 | RECRUITING | Moderate Pain in Knee Osteoarthritis; Severe Pain in Knee Osteoarthritis |
Shandong Suncadia Medicine Co., Ltd. |
2026-03-10 | PHASE1 |
| NCT05415397 | ACTIVE_NOT_RECRUITING | Depressive Disorder, Major; Inflammation |
Amsterdam UMC, location VUmc |
2022-09-28 | PHASE3 |
| NCT07543796 | RECRUITING | Postoperative Analgesia After Unilateral Hip Arthroplasty |
Beijing Tide Pharmaceutical Co., Ltd |
2026-03-18 | PHASE2 |
| NCT06545526 | UNKNOWN | Familial Adenomatous Polyposis |
Yonsei University |
2024-08-13 | PHASE3 |
| NCT05852093 | NOT_YET_RECRUITING | Rotator Cuff Tears |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-06-01 | EARLY_PHASE1 |
| NCT02574728 | ACTIVE_NOT_RECRUITING | Cancer |
Emory University |
2015-06 | PHASE2 |
| NCT06379425 | RECRUITING | Pain, Postoperative; Postoperative Pain, Acute |
Northwell Health |
2024-03-01 | PHASE4 |
| NCT00268476 | ACTIVE_NOT_RECRUITING | Prostate Cancer |
Medical Research Council |
2005-07-08 | PHASE2; PHASE3 |
| NCT04147013 | ACTIVE_NOT_RECRUITING | Chronic Rhinosinusitis with Nasal Polyps; Aspirin-exacerbated Respiratory Disease |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2020-02-18 | PHASE4 |
| NCT01344200 | RECRUITING | Pharmacokinetics of Celecoxib in Children |
Children's Hospital of Eastern Ontario |
2024-01-29 | PHASE2 |
| NCT06076837 | TERMINATED | Pancreatic Cancer Metastatic; Pancreatic Adenocarcinoma Metastatic |
HonorHealth Research Institute |
2025-01-09 | PHASE1 |
| NCT05077332 | COMPLETED | 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019-nCoV Disease; 2019-nCoV Infection; COVID-19 Pandemic; COVID-19 Virus Disease; COVID-19 Virus Infection; Covid19; Coronavirus Disease 2019; SARS-CoV-2 Infection; SARS-CoV-2 Acute Respiratory Disease; COVID-19 |
Leidos Life Sciences |
2021-12-29 | PHASE2 |
| NCT06863636 | RECRUITING | Joint Pain; Knee Osteoarthritis; Hip Osteoarthritis |
Laboratorios Silanes S.A. de C.V. |
2024-09-09 | PHASE3 |
| NCT05933980 | UNKNOWN | Colorectal Cancer; Liver Metastases; MSS |
Sun Yat-sen University |
2023-12-19 | PHASE2 |
| NCT07559682 | ACTIVE_NOT_RECRUITING | Orthodontic Pain (D013850) |
Sharif Medical Research Center |
2025-05-08 | PHASE1 |
| NCT04814355 | COMPLETED | Major Depressive Disorder; Neuroinflammation |
Stony Brook University |
2018-08-01 | PHASE4 |
| NCT03645187 | UNKNOWN | Colon Cancer Stage |
Sherief Abd-Elsalam |
2018-08-01 | PHASE4 |
| NCT02432378 | WITHDRAWN | Cancer of Ovary; Cancer of the Ovary; Neoplasms, Ovarian; Ovarian Cancer; Ovary Cancer; Ovary Neoplasms |
Roswell Park Cancer Institute |
2015-09-04 | PHASE1; PHASE2 |
| NCT06451783 | UNKNOWN | Osteoarthritis of the Knee |
Xuhui Central Hospital, Shanghai |
2024-05-01 | EARLY_PHASE1 |
| NCT05756166 | TERMINATED | Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma; Unresectable Triple-Negative Breast Carcinoma |
Roswell Park Cancer Institute |
2024-02-16 | PHASE1; PHASE2 |
| NCT04093323 | TERMINATED | HLA-A2 Positive Cells Present; Refractory Melanoma |
Roswell Park Cancer Institute |
2024-11-13 | PHASE2 |
| NCT06285617 | UNKNOWN | Subacute Thyroiditis |
Xinqiao Hospital of Chongqing |
2024-04-01 | PHASE3 |
| NCT06159114 | COMPLETED | Chronic Prostatitis |
Xintian Pharmaceutical |
2023-12-19 | PHASE4 |
| NCT06516094 | COMPLETED | Chronic Low-back Pain |
Laboratorios Silanes S.A. de C.V. |
2024-04-11 | PHASE3 |
| NCT05578287 | UNKNOWN | Colorectal Cancer |
Sun Yat-sen University |
2023-07-18 | PHASE2 |
| NCT05488847 | ACTIVE_NOT_RECRUITING | Shoulder Arthropathy; Shoulder Pain |
Henry Ford Health System |
2022-06-25 | PHASE4 |
| NCT06316843 | COMPLETED | Long COVID; PASC Post Acute Sequelae of COVID 19 |
Bateman Horne Center |
2023-10-15 | PHASE2 |
| NCT06337422 | UNKNOWN | Healthy Volunteer |
International Bio service |
2024-09-23 | PHASE1 |
| NCT05962957 | COMPLETED | Parkinson Disease |
Mostafa Bahaa |
2023-08-07 | PHASE2 |
| NCT04120636 | UNKNOWN | Macula Edema; Radiation Retinopathy; Branch Retinal Vein Occlusion; Epiretinal Membrane; Central Serous Retinopathy With Pit of Optic Disc; Commotio Retinae; Vitritis |
Targeted Therapy Technologies, LLC |
2021-03-05 | PHASE1 |
| NCT03912428 | TERMINATED | Myositis; Inflammatory; Rheumatoid Arthritis; Healthy Volunteers |
National Institute of Mental Health (NIMH) |
2019-06-14 | PHASE1 |
| NCT05327751 | UNKNOWN | Hand and Foot Syndrome; Erythrodysesthesia Syndrome; HFS; Colorectal Cancer |
Tanta University |
2022-04-01 | PHASE3 |
| NCT03710876 | COMPLETED | Malignant Pleural Mesothelioma |
Ferring Ventures Limited |
2019-01-21 | PHASE3 |
| NCT05281276 | TERMINATED | Metastatic Colorectal Cancer |
Taipei Medical University Shuang Ho Hospital |
2022-09-20 | PHASE1 |
| NCT02885974 | COMPLETED | Bladder Cancer |
Baylor College of Medicine |
2016-12 | PHASE1 |
| NCT01344200 | Recruiting | Pharmacokinetics of Celecoxib in Children |
Children''s Hospital of Eastern Ontario |
2024-01-29 | Phase 2 |
| NCT02030964 | COMPLETED | Neuroblastoma |
New Approaches to Neuroblastoma Therapy Consortium |
2014-01-16 | PHASE1 |
| NCT05288374 | COMPLETED | Pain, Postoperative |
Charles University, Czech Republic |
2022-02-10 | PHASE4 |
| NCT03728179 | COMPLETED | Solid Tumor, Adult |
Centre Hospitalier Universitaire Vaudois |
2019-01-16 | PHASE1 |
| NCT05911126 | UNKNOWN | Pain |
Cairo University |
2023-06-13 | |
| NCT05062083 | TERMINATED | Multiple Sclerosis |
National Institute of Mental Health (NIMH) |
2022-06-07 | PHASE2 |
| NCT06009900 | UNKNOWN | Pain, Chronic |
Tongji Hospital |
2023-09-01 | |
| NCT04115098 | TERMINATED | Axial Spondyloarthritis |
The University of Texas Health Science Center, Houston |
2020-06-25 | PHASE2 |
| NCT05555823 | COMPLETED | Healthy |
Atriva Therapeutics GmbH |
2022-06-23 | PHASE1 |
| NCT07804979 | COMPLETED | Major Depressive Disorder (MDD); Treatment-resistant Depression (TRD) |
Lahore General Hospital |
2022-05-12 | |
| NCT06336993 | COMPLETED | Low Back Pain |
Zhejiang Provincial Tongde Hospital |
2022-01-01 | PHASE4 |
| NCT05476679 | COMPLETED | Submental Fat |
Raziel Therapeutics Ltd. |
2022-09-25 | PHASE1; PHASE2 |
| NCT04673578 | UNKNOWN | Obsessive-Compulsive Disorder; Pediatric Psychiatric Disorder |
University of British Columbia |
2021-06-01 | PHASE2 |
| NCT05509946 | UNKNOWN | Arthroplasty Complications; Analgetic; Celecoxib; Pregabalin |
Indonesia University |
2022-10-01 | PHASE2; PHASE3 |
| NCT05512013 | COMPLETED | Bone Resorption; Stress Fracture; Bone Injury |
United States Army Research Institute of Environmental Medicine |
2022-02-15 | PHASE1 |
| NCT03643744 | TERMINATED | Actinic Keratosis; Photodynamic Therapy |
Wright State University |
2019-04-01 | PHASE1 |
| NCT04790812 | COMPLETED | Pain, Postoperative |
The University of Texas Health Science Center, Houston |
2021-04-22 | PHASE4 |
| NCT04162873 | TERMINATED | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Nasal Cavity and Paranasal Sinus Carcinoma; Oral Cavity Carcinoma; Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Recurrent Hypopharyngeal Carcinoma; Recurrent Laryngeal Carcinoma; Recurrent Nasal Cavity and Paranasal Sinus Carcinoma; Recurrent Oral Cavity Carcinoma; Recurrent Oropharyngeal Carcinoma; Stage III Hypopharyngeal Carcinoma AJCC v8; Stage III Laryngeal Cancer AJCC v8; Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IV Hypopharyngeal Carcinoma AJCC v8; Stage IV Laryngeal Cancer AJCC v8; Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVA Hypopharyngeal Carcinoma AJCC v8; Stage IVA Laryngeal Cancer AJCC v8; Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVB Hypopharyngeal Carcinoma AJCC v8; Stage IVB Laryngeal Cancer AJCC v8; Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVC Hypopharyngeal Carcinoma AJCC v8; Stage IVC Laryngeal Cancer AJCC v8; Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 |
University of Utah |
2019-11-27 | PHASE2 |
| NCT05085574 | WITHDRAWN | 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019-nCoV Disease; 2019-nCoV Infection; COVID-19 Pandemic; COVID-19 Virus Disease; COVID-19 Virus Infection; Covid19; Coronavirus Disease 2019; SARS-CoV-2 Infection; SARS-CoV-2 Acute Respiratory Disease; COVID-19 |
Leidos Life Sciences |
2023-02-07 | PHASE2 |
| NCT05324163 | COMPLETED | KNEE OSTEOARTHRITIS |
Jiangsu XinChen-Techfields Pharma Co., LTD. |
2021-09-29 | PHASE3 |
| NCT05362851 | UNKNOWN | Osteoarthritis, Knee |
Yooyoung Pharmaceutical Co., Ltd. |
2021-11-11 | PHASE3 |
| NCT04015908 | COMPLETED | Opioid Use |
University of Utah |
2019-08-01 | PHASE4 |
| NCT05438303 | COMPLETED | Healthy Volunteers |
AstraZeneca |
2022-06-13 | PHASE1 |
| NCT03699293 | TERMINATED | Rheumatoid Arthritis; Cardiovascular Diseases |
Platelet and Thrombosis Research, LLC |
2018-09-22 | PHASE4 |
| NCT04718649 | UNKNOWN | Osteoarthritis |
The Catholic University of Korea |
2021-01 | |
| NCT04082715 | WITHDRAWN | Chronic Back Pain |
Second Affiliated Hospital of Wenzhou Medical University |
2019-10 | PHASE2 |
| NCT02502006 | TERMINATED | Healthy |
University of Pennsylvania |
2015-11 | PHASE1 |
| NCT05436678 | COMPLETED | Pharmacokinetics |
NeuroSense Therapeutics Ltd. |
2022-07-26 | PHASE1 |
| NCT05648916 | Enrolling by invitation | Heterotopic Ossification |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2022-08-02 | -- |
| NCT02389465 | COMPLETED | Depression; Inflammation |
University of Pennsylvania |
2014-08 | PHASE4 |
| NCT05237297 | COMPLETED | Drug Interaction Potentiation |
Il-Yang Pharm. Co., Ltd. |
2022-02-17 | PHASE1 |
| NCT03896113 | UNKNOWN | Endometrium Cancer |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2019-11-13 | PHASE2 |
| NCT05077969 | TERMINATED | 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019-nCoV Disease; 2019-nCoV Infection; COVID-19; COVID-19 Pandemic; COVID-19 Virus Disease; COVID-19 Virus Infection; Covid19; Coronavirus Disease 2019; SARS-CoV2 Infection; SARS-CoV-2 Acute Respiratory Disease |
Leidos Life Sciences |
2021-12-29 | PHASE2 |
| NCT04429022 | COMPLETED | Pain, Postoperative |
State University of New York at Buffalo |
2020-11-24 | PHASE3 |
| NCT04081389 | COMPLETED | Anatomic Stage 0 Breast Cancer AJCC v8; Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Early-Stage Breast Carcinoma; Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Prognostic Stage 0 Breast Cancer AJCC v8; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Triple-Negative Breast Carcinoma |
Roswell Park Cancer Institute |
2019-12-06 | PHASE1 |
| NCT05232461 | COMPLETED | Pharmacokinetics |
NeuroSense Therapeutics Ltd. |
2022-04-08 | PHASE1 |
| NCT05324995 | COMPLETED | Postoperative Pain; Total Knee Arthroplasty |
Isfahan University of Medical Sciences |
2021-01-01 | PHASE2 |
| NCT05256823 | Active not recruiting | To Evaluate the Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues in Nucleos(t)Ide-treated Patients With Chronic Hepatitis B |
Lai Wei|Beijing Tsinghua Chang Gung Hospital |
2022-02-24 | Phase 2 |
| NCT04765644 | COMPLETED | Healthy |
Imperial College London |
2021-06-10 | PHASE4 |
| NCT05994287 | COMPLETED | Postoperative Pain, Acute |
Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty |
2021-01-01 | |
| NCT04090684 | COMPLETED | ALS (Amyotrophic Lateral Sclerosis) |
NeuroSense Therapeutics Ltd. |
2019-12-09 | PHASE1 |
| NCT05324163 | Completed | KNEE OSTEOARTHRITIS |
Jiangsu XinChen-Techfields Pharma Co. LTD. |
2021-09-29 | Phase 3 |
| NCT04505657 | COMPLETED | IUCD Complication |
Aswan University Hospital |
2020-09-01 | |
| NCT03864575 | UNKNOWN | Metastatic Cancer |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2019-08-15 | PHASE2 |
| NCT04447261 | COMPLETED | Obesity |
Boehringer Ingelheim |
2020-06-30 | PHASE1 |
| NCT00503035 | COMPLETED | Familial Adenomatous Polyposis |
M.D. Anderson Cancer Center |
2003-08-20 | PHASE2 |
| NCT03084536 | COMPLETED | Breast Cancer; Breast Cancer Female; Cancer of Breast |
Washington University School of Medicine |
2017-06-07 | PHASE2 |
| NCT04165850 | COMPLETED | Amyotrophic Lateral Sclerosis; ALS |
NeuroSense Therapeutics Ltd. |
2019-11-25 | PHASE2 |
| NCT02758782 | COMPLETED | Ankylosing Spondylitis |
Charite University, Berlin, Germany |
2016-09 | PHASE4 |
| NCT03818919 | COMPLETED | Rotator Cuff Tear |
Henry Ford Health System |
2019-01-22 | PHASE2 |
| NCT03625050 | COMPLETED | Total Knee Replacement; Manipulation |
Gachon University Gil Oriental Medical Hospital |
2018-11-01 | PHASE2 |
| NCT03403634 | COMPLETED | Metastatic Carcinoma in the Liver; Recurrent Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v7; Stage IVA Colorectal Cancer AJCC v7; Stage IVB Colorectal Cancer AJCC v7 |
Roswell Park Cancer Institute |
2018-04-19 | PHASE2 |
| NCT03878524 | TERMINATED | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8; Anemia; Ann Arbor Stage III Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Castration-Resistant Prostate Carcinoma; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid System Neoplasm; Locally Advanced Pancreatic Adenocarcinoma; Metastatic Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Pancreatic Adenocarcinoma; Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Primary Myelofibrosis; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Hematologic Malignancy; Recurrent Hodgkin Lymphoma; Recurrent Myelodysplastic Syndrome; Recurrent Myelodysplastic/Myeloproliferative Neoplasm; Recurrent Myeloproliferative Neoplasm; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Chronic Myelomonocytic Leukemia; Refractory Hematologic Malignancy; Refractory Hodgkin Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Myelodysplastic Syndrome; Refractory Myelodysplastic/Myeloproliferative Neoplasm; Refractory Non-Hodgkin Lymphoma; Refractory Plasma Cell Myeloma; Refractory Primary Myelofibrosis; Refractory Small Lymphocytic Lymphoma; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Unresectable Pancreatic Adenocarcinoma |
OHSU Knight Cancer Institute |
2020-04-01 | PHASE1 |
| NCT04259333 | UNKNOWN | Pain, Postoperative; Surgery--Complications; Opioid Analgesic Adverse Reaction; Opioid Use |
Blake Raggio |
2020-03-01 | PHASE4 |
| NCT03121963 | WITHDRAWN | Pain Management |
University of Alabama at Birmingham |
2017-11-10 | PHASE4 |
| NCT04526197 | COMPLETED | Wilson Disease |
Alexion Pharmaceuticals, Inc. |
2020-07-07 | PHASE1 |
| NCT03599453 | COMPLETED | Triple -Negative Breast Cancer; Estrogen Receptor Negative; HER2/Neu Negative; Anatomic Stage IV Breast Cancer AJCC; Progesterone Receptor Negative |
Roswell Park Cancer Institute |
2019-01-09 | EARLY_PHASE1 |
| NCT04490434 | UNKNOWN | Healthy Male Volunteers |
Daewoong Pharmaceutical Co. LTD. |
2020-06-19 | PHASE1 |
| NCT03949673 | TERMINATED | Osteoarthritis, Knee; Osteoarthritis, Hip |
Regeneron Pharmaceuticals |
2019-04-08 | PHASE2 |
| NCT02876094 | TERMINATED | Spinal Muscular Atrophy (SMA) |
Hugh McMillan |
2019-01-29 | PHASE2 |
| NCT04639804 | COMPLETED | Healthy |
HK inno.N Corporation |
2020-06-06 | PHASE1 |
| NCT02827487 | UNKNOWN | Pain |
Cairo University |
2016-07-01 | PHASE4 |
| NCT04526197 | Completed | Wilson Disease |
Alexion Pharmaceuticals Inc. |
2020-07-07 | Phase 1 |
| NCT03820193 | COMPLETED | Meniscus Disorder; Narcotic Use |
Henry Ford Health System |
2019-01-22 | EARLY_PHASE1 |
| NCT04020588 | UNKNOWN | Schizophrenia |
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico |
2019-02-25 | PHASE4 |
| NCT03850587 | COMPLETED | Osteoarthritis, Knee |
Yooyoung Pharmaceutical Co., Ltd. |
2018-08-30 | PHASE2 |
| NCT05547659 | COMPLETED | Compare Unimodal and Multimodal Analgesics |
October 6 University |
2019-01-01 | PHASE1; PHASE2 |
| NCT01313429 | TERMINATED | Sarcoma; Melanoma; Epithelial Malignancies; Pleural Malignancies |
National Cancer Institute (NCI) |
2011-03-04 | PHASE1 |
| NCT04342065 | COMPLETED | Post-Operative Pain |
South Egypt Cancer Institute |
2019-01-01 | PHASE2; PHASE3 |
| NCT03818932 | COMPLETED | Anterior Cruciate Ligament Injury |
Henry Ford Health System |
2019-01-22 | PHASE2; PHASE3 |
| NCT03825809 | RECRUITING | Narcotic Use |
Henry Ford Health System |
2019-01-22 | PHASE2; PHASE3 |
| NCT02160301 | WITHDRAWN | Post Operative Pain Control |
University of North Carolina, Chapel Hill |
2017-11 | PHASE4 |
| NCT04374981 | COMPLETED | Food-drug Interaction |
Damanhour University |
2019-07-01 | PHASE2 |
| NCT03885596 | COMPLETED | Pain |
Concentric Analgesics |
2019-03-25 | PHASE2 |
| NCT03464552 | COMPLETED | Colposcopy |
Cairo University |
2018-04-15 | PHASE4 |
| NCT02845336 | TERMINATED | Thyroid Eye Disease |
Johns Hopkins University |
2017-03-05 | PHASE2 |
| NCT03541655 | COMPLETED | Total Knee Replacement; Postoperative Pain |
Arthritis Innovation Corporation |
2018-05-04 | PHASE2 |
| NCT03570554 | COMPLETED | Osteoarthritis, Knee |
Bayer |
2018-06-29 | PHASE2 |
| NCT02725411 | COMPLETED | Low Back Pain |
Pfizer |
2016-05-26 | PHASE3 |
| NCT03586934 | WITHDRAWN | Shoulder Pain; Opioid Use |
Rush University Medical Center |
2018-06-01 | PHASE3 |
| NCT02667730 | COMPLETED | Ligament Injury |
Canadian Department of National Defence |
2015-06 | PHASE4 |
| NCT03337607 | COMPLETED | Low Back Pain |
First Affiliated Hospital of Zhejiang University |
2017-11-13 | |
| NCT02362529 | COMPLETED | Major Depressive Disorder |
Centre for Addiction and Mental Health |
2015-02 | EARLY_PHASE1 |
| NCT02429427 | COMPLETED | Breast Cancer |
Imperial College London |
2005-12 | PHASE3 |
| NCT03059238 | COMPLETED | Liver Cancer; Pain Postoperative |
Sun Yat-sen University |
2016-09 | PHASE3 |
| NCT02151448 | COMPLETED | Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface; Malignant Peritoneal Mesothelioma; Peritoneal Carcinomatosis |
David Bartlett |
2014-07 | PHASE1; PHASE2 |
| NCT03672162 | COMPLETED | Total Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , Celecoxib |
Department of Medical Services Ministry of Public Health of Thailand |
2019-02-01 | |
| NCT02726659 | TERMINATED | Bipolar Disorder; Postpartum Depression |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2016-05 | PHASE3 |
| NCT03404479 | UNKNOWN | Knee Osteoarthritis |
Whan-Seok Choi |
2018-01-25 | PHASE4 |
| NCT02280694 | COMPLETED | Colorectal Cancer |
HaEmek Medical Center, Israel |
2015-01 | PHASE2 |
| NCT02790203 | UNKNOWN | Prevention of Post Operative Ileus |
Sheba Medical Center |
2016-06 | |
| NCT02703363 | COMPLETED | Depression; Bipolar Disorder; Bipolar Depression; Mood Disorders |
Pakistan Institute of Living and Learning |
2016-08 | PHASE3 |
| NCT02484664 | COMPLETED | Lymphangioleiomyomatosis (LAM) |
Brigham and Women's Hospital |
2016-06-15 | PHASE2 |
| NCT02770378 | COMPLETED | Glioblastoma |
University of Ulm |
2016-11 | PHASE1; PHASE2 |
| NCT02260336 | UNKNOWN | Rheumatic Pain |
Chengdu PLA General Hospital |
2014-10 | |
| NCT03554772 | COMPLETED | Acute Pain |
Dr. Reddy's Laboratories Limited |
2018-06-19 | PHASE2 |
| NCT02934191 | COMPLETED | Tonsillectomy |
Children's Hospital of Philadelphia |
2016-06 | PHASE2 |
| NCT02688400 | COMPLETED | Osteoarthritis; Osteoarthritis, Knee |
TRB Chemedica International SA |
2016-05 | PHASE3 |
| NCT03190603 | COMPLETED | Spondylarthropathies; Magnetic Resonance Imaging |
Armed Forces Capital Hospital, Republic of Korea |
2018-06-01 | PHASE4 |
| NCT02615574 | WITHDRAWN | Metastatic Colorectal Cancer |
Pawel Kalinski |
2016-03 | PHASE2 |
| NCT03822520 | COMPLETED | Qt Interval, Variation in |
Samsung Medical Center |
2017-06-30 | PHASE1 |
| NCT02108366 | COMPLETED | Influenza, Human |
The University of Hong Kong |
2014-03 | PHASE3 |
| NCT02987920 | TERMINATED | Pain, Postoperative |
University of Southern California |
2017-01 | PHASE4 |
| NCT01479829 | COMPLETED | Bipolar Depression |
Loyola University |
2011-03-23 | PHASE4 |
| NCT03108482 | COMPLETED | Acute Post-surgical Pain |
Esteve Pharmaceuticals, S.A. |
2017-03-14 | PHASE3 |
| NCT02979197 | COMPLETED | Hypertension |
Kitov Pharma Ltd |
2016-11-03 | PHASE3 |
| NCT03067194 | COMPLETED | Osteoarthritis Hand |
Chong Kun Dang Pharmaceutical |
2016-12-27 | PHASE4 |
| NCT02703259 | COMPLETED | Pain, Postoperative |
Christiana Care Health Services |
2016-06 | PHASE4 |
| NCT01111591 | UNKNOWN | Bile Duct Cancer; Pancreatic Cancer |
Seoul National University Hospital |
2008-11 | PHASE4 |
| NCT02759198 | COMPLETED | Knee Osteoarthritis |
Yuhan Corporation |
2016-05-02 | PHASE2 |
| NCT02711579 | COMPLETED | Electrophysiologic Property of Brain |
Seoul National University Hospital |
2016-05 | PHASE1 |
| NCT02839694 | WITHDRAWN | Neoplasm Metastasis; Sarcoma; Neoplasms, Germ Cell and Embryonal; Melanoma |
National Cancer Institute (NCI) |
2016-07-07 | PHASE1 |
| NCT02736019 | UNKNOWN | Hysteroscopy |
Cairo University |
2016-06 | PHASE3 |
| NCT02736071 | UNKNOWN | Hysteroscopy |
Cairo University |
2016-06 | PHASE3 |
| NCT02638896 | UNKNOWN | Ankylosing Spondylitis |
Zhixiang Huang |
2016-01 | PHASE4 |
| NCT02268825 | TERMINATED | Advanced GI Cancer |
University of Utah |
2015-01-23 | PHASE1 |
| NCT01041781 | TERMINATED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2010-02 | PHASE3 |
| NCT00223691 | COMPLETED | Autonomic Failure; Orthostatic Hypotension |
Vanderbilt University |
2002-03 | PHASE1 |
| NCT00153673 | COMPLETED | Arthritis; Gastric Ulcer |
Chinese University of Hong Kong |
2001-02 | PHASE3 |
| NCT03523832 | COMPLETED | Acute Pain |
Fakultas Kedokteran Universitas Indonesia |
2015-07-01 | PHASE2 |
| NCT02307305 | UNKNOWN | Neuropathic Pain |
Hanyang University Seoul Hospital |
2014-08 | PHASE2 |
| NCT02537925 | UNKNOWN | Nasopharyngeal Carcinoma |
Changjie Huang |
2014-01 | PHASE3 |
| NCT02739204 | UNKNOWN | Oral Squamous Cell Carcinoma |
China Medical University Hospital |
2013-11 | PHASE2 |
| NCT02131012 | TERMINATED | Inflammation |
Vanderbilt University |
2015-06 | PHASE1 |
| NCT02198924 | COMPLETED | Pain; Inflammation |
Peking Union Medical College Hospital |
2014-12 | PHASE4 |
| NCT01425476 | COMPLETED | Breast Cancer |
Hartford Hospital |
2008-07 | PHASE1; PHASE2 |
| NCT01769625 | COMPLETED | Biomarker Change Linked to Breast Cancer |
Hartford Hospital |
2009-01 | PHASE1; PHASE2 |
| NCT02600247 | UNKNOWN | Osteoarthritis |
The Catholic University of Korea |
2015-11 | |
| NCT02301234 | COMPLETED | Osteoarthritis; Pain |
Janssen Research & Development, LLC |
2015-03-25 | PHASE3 |
| NCT01729923 | TERMINATED | Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer |
University of Washington |
2013-03 | PHASE2 |
| NCT02961998 | COMPLETED | Hepatocellular Carcinoma |
Sun Yat-sen University |
2015-07 | PHASE4 |
| NCT03331315 | COMPLETED | Pain, Postoperative |
Michael Ulm, MD |
2013-09-01 | PHASE2 |
| NCT01258868 | TERMINATED | Mesolthelioma; Esophageal Cancer; Lung Cancer; Thoracic Sarcomas; Thymoma |
National Cancer Institute (NCI) |
2010-12-01 | PHASE1 |
| NCT01341496 | TERMINATED | Sarcoma; Melanoma; Epithelial Malignancies; Pleural Malignancy |
National Cancer Institute (NCI) |
2011-04-18 | PHASE1 |
| NCT00346216 | COMPLETED | Arthritis, Rheumatoid |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2006-10-04 | PHASE4 |
| NCT02351934 | COMPLETED | Colorectal Disorders |
Mayo Clinic |
2015-02 | PHASE4 |
| NCT01705106 | TERMINATED | Unspecified Adult Solid Tumor, Protocol Specific |
University of Chicago |
2012-08-29 | PHASE1 |
| NCT02602509 | COMPLETED | Tuberculosis |
National University Hospital, Singapore |
2015-11 | PHASE1 |
| NCT01796951 | COMPLETED | Tobacco Use Disorder; Smoking |
Vanderbilt University |
2013-02 | EARLY_PHASE1 |
| NCT02779166 | COMPLETED | Hip Labral Tears |
Northwestern University |
2012-08 | |
| NCT02355236 | UNKNOWN | Osteoarthritis |
Severance Hospital |
2015-02 | PHASE4 |
| NCT02172040 | COMPLETED | Hypertension |
Kitov Pharmaceuticals, Ltd. |
2014-06-26 | PHASE3 |
| NCT02413203 | COMPLETED | Healthy |
University of Pennsylvania |
2015-03 | |
| NCT02850211 | COMPLETED | Rotator Cuff Tear |
Seoul National University Bundang Hospital |
2011-09 | PHASE4 |
| NCT02079727 | COMPLETED | Knee Osteoarthritis |
IBSA Institut Biochimique SA |
2014-06-12 | PHASE3 |
| NCT01934933 | COMPLETED | Ankylosing Spondylitis |
Sun Yat-sen University |
2014-09-24 | PHASE4 |
| NCT01285817 | COMPLETED | Survival Without Progression |
Assistance Publique Hopitaux De Marseille |
2011-01-12 | PHASE2 |
| NCT00447759 | COMPLETED | Osteoarthritis; Rheumatoid Arthritis |
University of Dundee |
2007-06 | PHASE4 |
| NCT02401295 | COMPLETED | Relapsed Multiple Myeloma |
University of Iowa |
2015-05 | PHASE1 |
| NCT02502500 | COMPLETED | Healthy Volunteers |
Akebia Therapeutics |
2015-07 | PHASE1 |
| NCT02408146 | UNKNOWN | Pain, Postoperative |
First Affiliated Hospital of Harbin Medical University |
2014-01 | |
| NCT02054104 | TERMINATED | Thoracic Sarcomas; Thorasic Cancers; Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura; Sarcoma; Melanoma |
National Cancer Institute (NCI) |
2014-09-03 | PHASE1; PHASE2 |
| NCT01631669 | UNKNOWN | Ossification, Heterotopic |
Walter Reed National Military Medical Center |
2012-05 | |
| NCT01838044 | TERMINATED | Chronic Low Back Pain With a Neuropathic Component |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2013-10 | PHASE4 |
| NCT01143545 | TERMINATED | Lung Cancer; Esophageal Cancer; Malignant Pleural Mesothelioma; Sarcoma; Thymic Carcinoma |
National Cancer Institute (NCI) |
2010-12-07 | PHASE1 |
| NCT00159484 | COMPLETED | Colon Cancer; Colorectal Cancer |
University of Southern California |
2004-10-12 | PHASE1; PHASE2 |
| NCT00571701 | COMPLETED | Recurrent Respiratory Papillomatosis |
Northwell Health |
2008-02 | PHASE2 |
| NCT01709656 | COMPLETED | Ankylosing Spondylitis |
Sun Yat-sen University |
2012-03 | |
| NCT02179645 | COMPLETED | Healthy |
Glenmark Pharmaceuticals Ltd. India |
2014-05 | PHASE1 |
| NCT01503385 | UNKNOWN | Lung Cancer |
Chinese Academy of Medical Sciences |
2011-12 | PHASE2 |
| NCT01220973 | COMPLETED | Prostate Cancer |
Rutgers, The State University of New Jersey |
2009-02 | PHASE2 |
| NCT02071303 | COMPLETED | Pain |
Cairo University |
2014-05 | PHASE2 |
| NCT00153660 | COMPLETED | Arthritis; Cardiovascular Diseases; Cerebrovascular Disorders |
Chinese University of Hong Kong |
2005-06 | PHASE3 |
| NCT01768520 | COMPLETED | Knee Osteoarthritis |
Hanlim Pharm. Co., Ltd. |
2012-07-02 | PHASE3 |
| NCT00104767 | COMPLETED | Lung Cancer |
Jonsson Comprehensive Cancer Center |
2009-01 | PHASE1 |
| NCT02084511 | COMPLETED | Pain, Postoperative |
Boehringer Ingelheim |
2014-03 | PHASE1 |
| NCT01354145 | COMPLETED | Knee Osteoarthritis |
Bioiberica |
2011-06 | PHASE3 |
| NCT00112502 | COMPLETED | Brain and Central Nervous System Tumors; Glioblastoma Multiforme |
M.D. Anderson Cancer Center |
2005-09 | PHASE2 |
| NCT01901679 | COMPLETED | Obesity |
Rockefeller University |
2013-07 | EARLY_PHASE1 |
| NCT02037165 | COMPLETED | Healthy |
Boehringer Ingelheim |
2014-01-21 | PHASE1 |
| NCT01968070 | COMPLETED | Healthy Volunteers |
Eli Lilly and Company |
2013-10 | PHASE1 |
| NCT01067989 | TERMINATED | Chemotherapy; Breast Cancer, Metastatic |
HaEmek Medical Center, Israel |
2010-03 | PHASE2 |
| NCT01881048 | COMPLETED | Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer |
University of Colorado, Denver |
2009-12-08 | EARLY_PHASE1 |
| NCT01765296 | COMPLETED | Localized Primary Osteoarthritis of Hip; Localized Primary Osteoarthritis of Knee |
CrystalGenomics, Inc. |
2013-03 | PHASE3 |
| NCT01849055 | COMPLETED | Healthy Volunteers |
Eli Lilly and Company |
2013-05 | PHASE1 |
| NCT01756989 | COMPLETED | Brainstem Glioma |
Helsinki University Central Hospital |
2005-01 | PHASE2 |
| NCT01668680 | TERMINATED | Colorectal Cancer Metastatic |
HaEmek Medical Center, Israel |
2012-09 | PHASE2 |
| NCT00520845 | TERMINATED | Lung Cancer |
Vanderbilt-Ingram Cancer Center |
2007-10 | PHASE2 |
| NCT02343614 | COMPLETED | Non Muscle Invasive Bladder Cancer |
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari |
2003-03 | PHASE2 |
| NCT00585312 | TERMINATED | Adenomatous Polyposis Coli |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2006-09 | PHASE3 |
| NCT01678313 | COMPLETED | Benign Prostatic Hyperplasia |
Buddhist Tzu Chi General Hospital |
2012-08 | PHASE2 |
| NCT01555073 | TERMINATED | Uterine Fibroids; Uterine Artery Embolization |
Northwestern University |
2011-10 | PHASE4 |
| NCT01623921 | UNKNOWN | Blunt Chest Trauma; Acute Respiratory Distress Syndrome |
Tel-Aviv Sourasky Medical Center |
2012-08 | |
| NCT00780325 | TERMINATED | Healthy Volunteers |
University of Pennsylvania |
2008-10 | PHASE1 |
| NCT01175772 | TERMINATED | Ovarian Carcinoma |
HaEmek Medical Center, Israel |
2010-08 | PHASE2 |
| NCT01186887 | COMPLETED | Pain |
Ottawa Hospital Research Institute |
2009-02 | |
| NCT01632566 | TERMINATED | Healthy Volunteers |
Eli Lilly and Company |
2012-06 | PHASE1 |
| NCT01554163 | COMPLETED | Osteoarthritis of the Knee |
Organon and Co |
2012-03 | PHASE3 |
| NCT00357500 | COMPLETED | Central Nervous System Tumor, Pediatric; Leukemia; Lymphoma; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific |
Dana-Farber Cancer Institute |
2005-01 | PHASE2 |
| NCT01323595 | TERMINATED | Pain |
Weill Medical College of Cornell University |
2011-01 | |
| NCT00400374 | COMPLETED | Head and Neck Cancer |
Emory University |
2007-08 | PHASE1 |
| NCT00250835 | TERMINATED | Rectal Cancer |
New Mexico Cancer Research Alliance |
2005-04 | PHASE2 |
| NCT00807846 | COMPLETED | Arthritis, Juvenile Rheumatoid |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2009-09 | PHASE4 |
| NCT00314262 | COMPLETED | Precancerous Conditions |
Emory University |
2006-10 | PHASE1; PHASE2 |
| NCT00698204 | COMPLETED | Oral Mucositis |
UConn Health |
2003-07 | PHASE2 |
| NCT00081263 | COMPLETED | Cervical Carcinoma; Cervical Intraepithelial Neoplasia Grade 2/3; Stage 0 Cervical Cancer |
Gynecologic Oncology Group |
2005-06 | PHASE2 |
| NCT01632579 | COMPLETED | Healthy Volunteers |
Eli Lilly and Company |
2012-06 | PHASE1 |
| NCT00849966 | COMPLETED | Tonsillectomy; Adenotonsillectomy; Pain, Postoperative |
Children's Hospital of Eastern Ontario |
2009-08 | PHASE2 |
| NCT01021215 | COMPLETED | Tobacco Use Disorder |
National Cancer Institute (NCI) |
2010-05 | PHASE1; PHASE2 |
| NCT01549743 | COMPLETED | Healthy Male Volunteers |
Hanlim Pharm. Co., Ltd. |
2012-05-09 | PHASE1 |
| NCT01543685 | COMPLETED | Other Acute Postoperative Pain |
Iroko Pharmaceuticals, LLC |
2012-02 | PHASE3 |
| NCT00931203 | COMPLETED | Locally Advanced Rectal Cancer |
National Health Research Institutes, Taiwan |
2008-07 | PHASE2 |
| NCT00198081 | TERMINATED | Pancreas Neoplasms |
Indiana University |
2005-09 | PHASE2 |
| NCT00687388 | WITHDRAWN | Benign Prostatic Hyperplasia |
Samsung Medical Center |
2008-05 | PHASE4 |
| NCT01462435 | COMPLETED | Other Acute Postoperative Pain |
Iroko Pharmaceuticals, LLC |
2011-10 | PHASE3 |
| NCT00551889 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
City of Hope Medical Center |
2001-09 | PHASE1 |
| NCT00551005 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
City of Hope Medical Center |
2001-12 | PHASE1 |
| NCT02695745 | COMPLETED | Pain |
Purdue Pharma LP |
2011-09 | PHASE1 |
| NCT00135018 | COMPLETED | Breast Cancer |
Organisation for Oncology and Translational Research |
2006-02 | PHASE2 |
| NCT01280006 | COMPLETED | Obstructive Sleep Apnea; Hypertension; Cardiovascular Diseases; Stroke |
University of Calgary |
2011-01 | PHASE1; PHASE2 |
| NCT01341405 | COMPLETED | Osteoarthritis |
CrystalGenomics, Inc. |
2011-04 | PHASE2 |
| NCT01860833 | COMPLETED | Knee Osteoarthritis |
University of Catanzaro |
2010-04 | PHASE4 |
| NCT01304069 | COMPLETED | Healthy |
Turku University Hospital |
2011-01 | PHASE1 |
| NCT00808743 | COMPLETED | Familial Adenomatous Polyposis; Duodenal Neoplasms; Duodenal Polyps |
Radboud University Medical Center |
2009-05 | PHASE2; PHASE3 |
| NCT01284504 | TERMINATED | Colorectal Cancer; Colon Cancer |
Stanford University |
2011-01 | |
| NCT00538031 | COMPLETED | Fallopian Tube Cancer; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer |
City of Hope Medical Center |
2003-12-22 | PHASE2 |
| NCT00152828 | COMPLETED | Cervix Neoplasms |
University Health Network, Toronto |
2001-02 | PHASE1; PHASE2 |
| NCT00970502 | COMPLETED | Cancer of the Pharynx; Cancer of the Larynx; Cancer of the Neck; Paranasal Sinus Neoplasms; Cancer of the Head |
Johnny Kao |
2007-02 | PHASE1; PHASE2 |
| NCT00373685 | COMPLETED | Osteoarthritis |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2006-10 | PHASE4 |
| NCT01158534 | COMPLETED | Renal Cell Cancer; Stage IV Renal Cell Cancer |
Case Comprehensive Cancer Center |
2006-03 | PHASE2 |
| NCT00504660 | COMPLETED | Anaplastic Glioma of Brain; Glioblastoma Multiforme; Brain Cancer |
M.D. Anderson Cancer Center |
2003-09 | PHASE2 |
| NCT01062113 | COMPLETED | Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2010-04 | PHASE2 |
| NCT00177866 | TERMINATED | Crohn's Disease |
University of Pittsburgh |
2003-12 | PHASE4 |
| NCT00581685 | COMPLETED | Osteoarthritis |
Sunnybrook Health Sciences Centre |
2008-01 | PHASE3 |
| NCT00762463 | COMPLETED | Ankylosing Spondylitis |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2009-07 | PHASE3 |
| NCT00108186 | WITHDRAWN | Non-Small-Cell Lung Carcinoma |
US Department of Veterans Affairs |
2004-10 | PHASE1 |
| NCT00300729 | UNKNOWN | Non-Small Cell Lung Cancer |
University Hospital, Linkoeping |
2006-05 | PHASE3 |
| NCT00994461 | COMPLETED | Healthy Volunteers |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2009-11 | PHASE4 |
| NCT00070057 | COMPLETED | Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer |
National Cancer Institute (NCI) |
2003-04 | PHASE1 |
| NCT00894790 | TERMINATED | Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2009-11 | PHASE4 |
| NCT00442676 | WITHDRAWN | Preeclampsia |
Virginia Commonwealth University |
2009-06 | PHASE2 |
| NCT00291694 | COMPLETED | Breast Cancer |
Carol Fabian, MD |
2003-04 | PHASE2 |
| NCT00964431 | COMPLETED | Dental Pain |
Iroko Pharmaceuticals, LLC |
2009-08 | PHASE2 |
| NCT00589186 | UNKNOWN | Head and Neck Cancer |
National Cancer Centre, Singapore |
2007-11 | PHASE2 |
| NCT00549549 | COMPLETED | Arthritis, Gouty |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2008-02 | PHASE3 |
| NCT00985439 | COMPLETED | Dental Pain |
Iroko Pharmaceuticals, LLC |
2009-09 | PHASE2 |
| NCT00520338 | COMPLETED | Postoperative Pain; Thyroidectomy; Cyclooxygenase 2 Inhibitors |
Mahidol University |
2007-08 | PHASE4 |
| NCT00976716 | COMPLETED | Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2009-09 | PHASE3 |
| NCT01344213 | COMPLETED | Postoperative Pain Management; Total Knee Arthroplasty |
Chulalongkorn University |
2008-07 | PHASE4 |
| NCT00925106 | COMPLETED | Healthy Volunteers |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2009-07 | PHASE1 |
| NCT00598234 | COMPLETED | Osteoarthritis |
National Taiwan University Hospital |
2006-09 | PHASE4 |
| NCT00665457 | TERMINATED | Breast Cancer |
University of Nebraska |
2004-04-15 | PHASE2 |
| NCT00088972 | TERMINATED | Breast Cancer |
SWOG Cancer Research Network |
2004-11 | PHASE2 |
| NCT00484718 | TERMINATED | Osteoarthritis |
Pfizer |
2008-01-17 | PHASE4 |
| NCT00450736 | COMPLETED | Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma |
University of Miami |
2004-03 | PHASE1 |
| NCT00141102 | COMPLETED | Osteoarthritis; Arthritis, Rheumatoid |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2005-10 | PHASE4 |
| NCT00526214 | COMPLETED | Intracerebral Hemorrhage |
Seoul National University Hospital |
2007-10 | |
| NCT00813241 | COMPLETED | Healthy Volunteers |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2009-01 | PHASE1 |
| NCT00188565 | COMPLETED | Colorectal Neoplasms |
University Health Network, Toronto |
2004-03 | PHASE1; PHASE2 |
| NCT00033371 | COMPLETED | Colorectal Cancer; Familial Adenomatous Polyposis |
National Cancer Institute (NCI) |
2001-12-13 | PHASE2 |
| NCT01017380 | COMPLETED | Anterior Cruciate Ligament Injury |
Prince of Songkla University |
2008-01 | PHASE3 |
| NCT00624559 | COMPLETED | Hypertension |
University of Delaware |
2008-02 | PHASE4 |
| NCT00088959 | COMPLETED | Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
National Cancer Institute (NCI) |
2003-12 | PHASE1 |
| NCT00290680 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Medical University of South Carolina |
2005-03 | PHASE1 |
| NCT00664560 | COMPLETED | Osteoarthritis |
POZEN |
2008-04 | PHASE3 |
| NCT00665431 | COMPLETED | Osteoarthritis |
POZEN |
2008-04 | PHASE3 |
| NCT00546507 | COMPLETED | Osteoarthritis |
Mika Pharma GmbH |
2007-10 | PHASE3 |
| NCT00101686 | COMPLETED | Colorectal Neoplasms |
Pfizer |
2003-02 | PHASE3 |
| NCT00546832 | COMPLETED | Osteoarthritis |
Mika Pharma GmbH |
2007-10 | PHASE3 |
| NCT00662558 | COMPLETED | Low Back Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2008-01 | PHASE3 |
| NCT00585156 | TERMINATED | Bone Ingrowth; Pain |
University of Utah |
2008-06 | EARLY_PHASE1 |
| NCT00527982 | TERMINATED | Head and Neck Cancer; Lung Cancer |
M.D. Anderson Cancer Center |
2005-09 | PHASE2 |
| NCT00729495 | COMPLETED | Healthy Volunteer |
POZEN |
2008-07 | PHASE1 |
| NCT00304317 | WITHDRAWN | Ureteral Calculi |
University of Minnesota |
2006-03 | PHASE4 |
| NCT00466505 | COMPLETED | Colorectal Cancer |
Vanderbilt-Ingram Cancer Center |
2005-05 | PHASE2 |
| NCT00056082 | COMPLETED | Breast Cancer |
University of Kansas Medical Center |
2003-01 | PHASE2 |
| NCT00700687 | COMPLETED | Healthy |
POZEN |
2008-06 | PHASE1 |
| NCT00663767 | COMPLETED | Dental Pain |
Pfizer |
2008-04-07 | PHASE2 |
| NCT00582660 | COMPLETED | Colorectal Adenoma; Colorectal Carcinoma |
University of Alabama at Birmingham |
2001-12 | PHASE2 |
| NCT00099047 | COMPLETED | Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Smoldering Multiple Myeloma |
National Cancer Institute (NCI) |
2004-11 | PHASE2 |
| NCT00446797 | COMPLETED | Ankle Sprain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2007-05 | PHASE4 |
| NCT00038103 | COMPLETED | Breast Neoplasms |
Pfizer |
2002-01 | PHASE2 |
| NCT00055978 | COMPLETED | Lung Cancer |
University of California, Los Angeles |
2002-10 | PHASE2 |
| NCT00778193 | COMPLETED | Gastroduodenal Ulcer |
Research Associates of New York, LLP |
2007-10 | PHASE4 |
| NCT00139776 | COMPLETED | Osteoarthritis, Knee; Osteoarthritis, Hip |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2005-07 | PHASE4 |
| NCT00597415 | UNKNOWN | Osteoarthritis of the Knee |
University Hospitals Cleveland Medical Center |
2004-12 | PHASE2 |
| NCT00581971 | COMPLETED | Cancer |
University of Alabama at Birmingham |
2002-09 | PHASE1; PHASE2 |
| NCT00424294 | TERMINATED | Arthritis, Rheumatoid |
Pfizer |
2006-06 | PHASE2 |
| NCT00402987 | COMPLETED | Pharyngitis |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2006-12-04 | PHASE3 |
| NCT00201773 | COMPLETED | Breast Cancer |
Ohio State University Comprehensive Cancer Center |
2003-07 | PHASE2 |
| NCT00068653 | COMPLETED | Lung Cancer |
Barbara Ann Karmanos Cancer Institute |
2003-06 | PHASE2 |
| NCT01124435 | COMPLETED | Ovarian Neoplasms |
Catholic University of the Sacred Heart |
2003-10 | PHASE2 |
| NCT00081848 | COMPLETED | Liver Neoplasms |
National Cancer Institute (NCI) |
2004-04-20 | PHASE1 |
| NCT00603759 | UNKNOWN | Head and Neck Cancer |
Tehran University of Medical Sciences |
2006-04 | PHASE3 |
| NCT00256321 | TERMINATED | Gastric Carcinoma; Gastroesophageal Junction Carcinoma |
University of California, Irvine |
2004-10 | PHASE2 |
| NCT01695226 | COMPLETED | Breast Neoplasms; Breast Cancer |
Maastricht University Medical Center |
2004-02 | PHASE2 |
| NCT00981201 | COMPLETED | Smoking; Prevention |
M.D. Anderson Cancer Center |
2001-11 | PHASE3 |
| NCT00007189 | COMPLETED | Alzheimer Disease |
Seattle Institute for Biomedical and Clinical Research |
2001-01 | PHASE3 |
| NCT00039390 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2002-04 | PHASE1 |
| NCT00141193 | COMPLETED | Colorectal Adenoma |
Pfizer |
2001-02 | PHASE3 |
| NCT00258232 | COMPLETED | Colorectal Cancer |
Barbara Ann Karmanos Cancer Institute |
2002-01 | PHASE2 |
| NCT00212108 | COMPLETED | Nasopharyngeal Carcinoma |
National University Hospital, Singapore |
2003-11 | PHASE1; PHASE2 |
| NCT00057980 | COMPLETED | Liver Cancer |
Northwestern University |
2002-10 | PHASE1; PHASE2 |
| NCT00070486 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2003-12 | PHASE2 |
| NCT00058006 | COMPLETED | Head and Neck Cancer; Lung Cancer |
Northwestern University |
2002-09 | PHASE2 |
| NCT00290901 | COMPLETED | Back Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2006-03 | PHASE4 |
| NCT00177853 | TERMINATED | Pancreatic Cancer |
University of Pittsburgh |
2006-12 | PHASE1 |
| NCT00520091 | COMPLETED | Esophageal Cancer |
UNC Lineberger Comprehensive Cancer Center |
2005-03 | PHASE2 |
| NCT00062179 | COMPLETED | Lung Cancer |
Jonsson Comprehensive Cancer Center |
2003-03 | PHASE2 |
| NCT00596219 | COMPLETED | SQUAMOUS CELL CARCINOMA |
Memorial Sloan Kettering Cancer Center |
2003-12 | |
| NCT00165451 | COMPLETED | Neoplasms |
Dana-Farber Cancer Institute |
2001-06 | PHASE2 |
| NCT00154219 | COMPLETED | Osteoarthritis, Hip |
Novartis |
2004-11 | PHASE3 |
| NCT00136487 | COMPLETED | Prostate Cancer |
Dana-Farber Cancer Institute |
2002-10 | PHASE2; PHASE3 |
| NCT01762891 | COMPLETED | Antiphospholipid Antibody Syndrome |
Hospital Universitario Pedro Ernesto |
2003-03 | |
| NCT00061906 | COMPLETED | Head and Neck Cancer |
Ohio State University Comprehensive Cancer Center |
2003-01 | PHASE2 |
| NCT00348491 | COMPLETED | Pain |
Novartis Pharmaceuticals |
2006-02 | PHASE4 |
| NCT00685568 | COMPLETED | Colorectal Cancer; Precancerous Condition |
M.D. Anderson Cancer Center |
2002-11-21 | PHASE1 |
| NCT00087256 | TERMINATED | Colorectal Cancer |
NSABP Foundation Inc |
2004-07 | PHASE3 |
| NCT00005094 | COMPLETED | Colon Cancer; Rectal Cancer |
National Cancer Institute (NCI) |
2000-03 | PHASE3 |
| NCT00084578 | WITHDRAWN | Bladder Cancer |
Fox Chase Cancer Center |
2004-03 | |
| NCT00137410 | COMPLETED | Osteoarthritis,Knee |
Pfizer |
2002-11 | PHASE3 |
| NCT00653250 | COMPLETED | Lung Cancer |
Vanderbilt-Ingram Cancer Center |
2000-12 | |
| NCT00006124 | COMPLETED | Recurrent Bladder Cancer |
National Cancer Institute (NCI) |
2000-06 | PHASE2; PHASE3 |
| NCT00081224 | TERMINATED | Colorectal Cancer |
Alliance for Clinical Trials in Oncology |
2004-12 | PHASE2 |
| NCT00183807 | TERMINATED | Esophageal Cancer |
University of Southern California |
2003-10 | PHASE2 |
| NCT00062101 | COMPLETED | Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
National Cancer Institute (NCI) |
2004-01 | PHASE2 |
| NCT00014404 | COMPLETED | Head and Neck Cancer |
Memorial Sloan Kettering Cancer Center |
2000-10 | PHASE2 |
| NCT00027976 | WITHDRAWN | Precancerous Condition |
University of Alabama at Birmingham |
2001-12 | PHASE2; PHASE3 |
| NCT00145301 | COMPLETED | Osteoarthritis |
Novartis |
2004-09 | PHASE3 |
| NCT00065169 | COMPLETED | Alzheimer Disease; Dementia |
University of California, Los Angeles |
2000-11 | |
| NCT00085163 | COMPLETED | Colorectal Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
2004-03 | PHASE3 |
| NCT00194090 | COMPLETED | Knee Osteoarthritis |
University Hospitals Cleveland Medical Center |
2004-06 | PHASE4 |
| NCT00030407 | COMPLETED | Lung Cancer |
Barbara Ann Karmanos Cancer Institute |
2001-10 | PHASE2 |
| NCT00005878 | COMPLETED | Esophageal Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2000-07 | PHASE2 |
| NCT00045591 | TERMINATED | Breast Cancer |
Alliance for Clinical Trials in Oncology |
2003-02 | PHASE2 |
| NCT00047281 | COMPLETED | Brain and Central Nervous System Tumors |
Dana-Farber Cancer Institute |
2004-03 | PHASE2 |
| NCT00068432 | COMPLETED | Pancreatic Cancer |
M.D. Anderson Cancer Center |
2003-12 | PHASE2 |
| NCT00009230 | COMPLETED | Memory Disorders |
University of California, Los Angeles |
2000-06 | PHASE3 |
| NCT00882388 | COMPLETED | Healthy |
Seoul National University Hospital |
2005-03 | PHASE4 |
| NCT00073970 | TERMINATED | Prostate Cancer |
UNC Lineberger Comprehensive Cancer Center |
2003-04 | PHASE2 |
| NCT00068770 | TERMINATED | Brain and Central Nervous System Tumors |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2003-10 | PHASE2 |
| NCT00084448 | TERMINATED | Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Gynecologic Oncology Group |
2004-04 | PHASE2 |
| NCT00494338 | TERMINATED | Metastatic Prostate Cancer |
Sanofi |
2004-11 | PHASE2 |
| NCT00084370 | WITHDRAWN | brca1 Mutation Carrier; brca2 Mutation Carrier; Ovarian Cancer |
University of Alabama at Birmingham |
2002-06 | |
| NCT00052611 | COMPLETED | Head and Neck Cancer |
Dana-Farber Cancer Institute |
2002-06 | PHASE2 |
| NCT00047294 | COMPLETED | Brain and Central Nervous System Tumors |
Dana-Farber Cancer Institute |
2001-04 | PHASE2 |
| NCT00092781 | COMPLETED | Osteoarthritis |
Organon and Co |
2004-03-01 | PHASE3 |
| NCT00092768 | COMPLETED | Osteoarthritis |
Organon and Co |
2004-03-01 | PHASE3 |
| NCT00022399 | COMPLETED | Prostate Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2002-04-25 | PHASE2 |
| NCT02840162 | TERMINATED | Adenocarcinoma of the Prostate; Prostate Cancer |
OHSU Knight Cancer Institute |
2001-05 | PHASE2 |
| NCT00064181 | COMPLETED | Colorectal Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
2003-05 | PHASE3 |
| NCT00643799 | COMPLETED | Osteoarthritis, Knee |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-03 | PHASE4 |
| NCT00101335 | COMPLETED | Head and Neck Cancer; Precancerous Condition |
Fox Chase Cancer Center |
2003-11 | PHASE2 |
| NCT00023660 | COMPLETED | Cervical Cancer |
Radiation Therapy Oncology Group |
2001-08 | PHASE1; PHASE2 |
| NCT00073866 | COMPLETED | Lung Cancer |
Northwestern University |
2003-06 | PHASE1; PHASE2 |
| NCT00475800 | COMPLETED | Osteoarthritis |
Novartis |
2004-01 | PHASE3 |
| NCT02090933 | COMPLETED | No Evidence of Disease |
National Cancer Institute (NCI) |
2004-03 | PHASE2 |
| NCT02528201 | COMPLETED | Ankylosing Spondylitis |
Pfizer |
2002-09 | PHASE4 |
| NCT00904605 | TERMINATED | Osteoarthritis of the Knee |
Endo USA Inc., a Keenova Therapeutics Company |
2004-06 | PHASE4 |
| NCT00476034 | COMPLETED | Osteoarthritis |
Novartis |
2003-12 | PHASE3 |
| NCT00904397 | TERMINATED | Chronic Low Back Pain |
Endo USA Inc., a Keenova Therapeutics Company |
2004-07 | PHASE4 |
| NCT00336960 | COMPLETED | Colorectal Cancer |
Vanderbilt-Ingram Cancer Center |
2002-07 | PHASE2 |
| NCT00137852 | COMPLETED | Esophageal Cancer |
Dana-Farber Cancer Institute |
2002-01 | PHASE2 |
| NCT00175032 | COMPLETED | Osteoarthritis; Peptic Ulcer |
Takeda |
2003-07 | PHASE3 |
| NCT00608595 | TERMINATED | Colorectal Cancer |
Vanderbilt-Ingram Cancer Center |
2002-07 | |
| NCT00030420 | COMPLETED | Lung Cancer |
Barbara Ann Karmanos Cancer Institute |
2001-10 | PHASE2 |
| NCT00080782 | TERMINATED | Metastatic Cancer; Prostate Cancer |
M.D. Anderson Cancer Center |
2002-02 | PHASE2 |
| NCT00652925 | COMPLETED | Arthritis, Juvenile Rheumatoid |
Pfizer |
2002-10 | PHASE3 |
| NCT00366938 | COMPLETED | Osteoarthritis, Knee |
Novartis |
2003-09 | PHASE3 |
| NCT00231829 | TERMINATED | Uterine Cancer |
Mark H. Einstein |
2003-04 | PHASE2 |
| NCT00367315 | COMPLETED | Knee Osteoarthritis |
Novartis |
2003-09 | PHASE3 |
| NCT00092352 | COMPLETED | Osteoarthritis |
Merck Sharp & Dohme LLC |
2003-04-29 | PHASE3 |
| NCT00092365 | COMPLETED | Osteoarthritis |
Merck Sharp & Dohme LLC |
2003-04-01 | PHASE3 |
| NCT00176813 | COMPLETED | Pancreatic Cancer |
University of Michigan Rogel Cancer Center |
2003-03 | PHASE2 |
| NCT00620867 | COMPLETED | Osteoarthritis, Knee |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2002-10 | PHASE4 |
| NCT00020878 | COMPLETED | Lung Cancer |
Jonsson Comprehensive Cancer Center |
2001-03 | PHASE2 |
| NCT02099136 | COMPLETED | No Evidence of Disease |
National Cancer Institute (NCI) |
1999-09 | PHASE2 |
| NCT00267215 | COMPLETED | Osteoarthritis |
Novartis |
2000-11 | PHASE3 |
| NCT00355576 | COMPLETED | Amyotrophic Lateral Sclerosis |
Columbia University |
2006-07 | PHASE2 |
| NCT00471341 | COMPLETED | Hypertension and Coronary Artery Disease |
University of Florida |
2002-07 | PHASE4 |
| NCT00072540 | WITHDRAWN | Stage 0 Cervical Cancer; High-grade Squamous Intraepithelial Lesion |
SWOG Cancer Research Network |
PHASE2 | |
| NCT00365313 | COMPLETED | Arthritis; Bleeding Ulcer |
Chinese University of Hong Kong |
2002-08 | PHASE3 |
| NCT00036283 | COMPLETED | Precancerous Conditions |
Pfizer |
2000-11 | PHASE2 |
| NCT00630929 | COMPLETED | Osteoarthritis, Knee |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2003-01 | PHASE4 |
| NCT00025051 | WITHDRAWN | Non-melanomatous Skin Cancer |
National Cancer Institute (NCI) |
PHASE2 | |
| NCT00328432 | COMPLETED | Breast Cancer |
University of Kansas |
2003-06 | PHASE1 |
| NCT00043043 | COMPLETED | Colorectal Cancer |
National Cancer Institute (NCI) |
2003-05 | PHASE2 |
| NCT00001693 | COMPLETED | Colorectal Neoplasm; Hereditary Nonpolyposis |
National Cancer Institute (NCI) |
1998-03 | PHASE1 |
| NCT00348452 | COMPLETED | Chronic Pain |
Bausch Health Americas, Inc. |
2002-09 | PHASE3 |
| NCT00218205 | UNKNOWN | Prostate Cancer |
Department of Veterans Affairs, New Jersey |
2002-07 | PHASE2 |
| NCT00141154 | COMPLETED | Low Back Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-10 | PHASE3 |
| NCT00565500 | COMPLETED | Ischemic Heart Disease; Osteoarthritis |
University of Chieti |
2003-04 | PHASE4 |
| NCT00638807 | COMPLETED | Osteoarthritis, Knee |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2003-12 | PHASE4 |
| NCT00357617 | UNKNOWN | Head and Neck Cancer |
Centre Hospitalier Universitaire Vaudois |
2006-06 | PHASE1; PHASE2 |
| NCT00043680 | COMPLETED | Macular Degeneration |
National Eye Institute (NEI) |
2002-08 | PHASE2 |
| NCT00163241 | TERMINATED | Osteoarthritis |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-06 | PHASE3 |
| NCT00648141 | COMPLETED | Spondylitis, Ankylosing |
Pfizer |
2003-01 | PHASE3 |
| NCT00072072 | COMPLETED | Lung Cancer |
Jonsson Comprehensive Cancer Center |
2003-08 | PHASE1 |
| NCT00181532 | COMPLETED | Non Small Cell Lung Carcinoma |
Maastricht Radiation Oncology |
2003-05 | PHASE2 |
| NCT00640432 | COMPLETED | Low Back Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2003-10 | PHASE4 |
| NCT00150280 | COMPLETED | Pain, Postoperative |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-10 | PHASE3 |
| NCT00215345 | UNKNOWN | Prostate Cancer |
Department of Veterans Affairs, New Jersey |
2002-08 | PHASE2 |
| NCT00359151 | TERMINATED | Osteoarthritis; Pain |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2006-11 | PHASE4 |
| NCT00640627 | COMPLETED | Osteoarthritis, Knee |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2003-12 | PHASE4 |
| NCT00640809 | COMPLETED | Bowel Diseases, Inflammatory |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2003-10 | PHASE4 |
| NCT00293436 | WITHDRAWN | Liver Cancer |
University of California, San Francisco |
2005-01 | PHASE1; PHASE2 |
| NCT00664690 | WITHDRAWN | Pain |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
PHASE4 | |
| NCT00065559 | TERMINATED | Diabetic Nephropathy |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2003-04 | |
| NCT00137033 | COMPLETED | Peptic Ulcers |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-09 | PHASE4 |
| NCT00633438 | COMPLETED | Arthroscopy |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-01 | PHASE4 |
| NCT00473980 | COMPLETED | Colorectal Cancer |
Göteborg University |
1998-12 | PHASE4 |
| NCT00093678 | WITHDRAWN | Cachexia; Lymphoma; Melanoma (Skin); Ovarian Cancer; Pain; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific |
Eastern Cooperative Oncology Group |
||
| NCT00032890 | COMPLETED | Osteoarthritis |
US Department of Veterans Affairs |
2000-04 | PHASE3 |
| NCT00050479 | COMPLETED | Macular Degeneration |
National Eye Institute (NEI) |
2002-12 | PHASE3 |
| NCT01020279 | COMPLETED | Musculoskeletal Pain |
X-pert Med GmbH |
2009-10 | PHASE1 |
| NCT00072553 | UNKNOWN | Colorectal Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2003-09 | PHASE2 |
| NCT00639483 | COMPLETED | Schizophrenia |
Pfizer |
2003-03 | PHASE2 |
| NCT00174317 | COMPLETED | Osteoarthritis, Hip |
Pfizer |
2003-08 | PHASE4 |
| NCT00317733 | COMPLETED | Osteoarthritis, Knee |
IDEA AG |
PHASE2 | |
| NCT00023621 | COMPLETED | Non-melanomatous Skin Cancer |
University of California, San Francisco |
2001-02 | PHASE2 |
| NCT00533247 | UNKNOWN | Postoperative Pain |
Zanbilowicz, Adam, DPM MS |
||
| NCT00006381 | COMPLETED | Breast Cancer |
Memorial Sloan Kettering Cancer Center |
2000-06 | PHASE2 |
| NCT00274898 | UNKNOWN | Lung Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2004-05 | PHASE2 |
| NCT00500279 | UNKNOWN | Angioplasty, Transluminal, Percutaneous Coronary; Coronary Restenosis |
Seoul National University Hospital |
2006-11 | PHASE4 |
| NCT00296127 | COMPLETED | Healthy Volunteers |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2006-02 | PHASE1 |
| NCT00211952 | SUSPENDED | Non-Small Cell Lung Cancer |
Medical University of Gdansk |
2004-03 | PHASE3 |
| NCT00633386 | COMPLETED | Arthroscopy |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2003-02 | PHASE4 |
| NCT00261586 | COMPLETED | Analgesics |
Johnson & Johnson Consumer and Personal Products Worldwide |
PHASE4 | |
| NCT00037180 | TERMINATED | Neoplasm Metastasis; Colorectal Neoplasms |
Pfizer |
2002-04 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2026-03-05)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Celecoxib (SC-58635) Mechanism of Action: COX-2 Inhibition in Cancer Cells Research
- Celecoxib (SC-58635) Working Concentration | Cell Culture | Treatment
- Celecoxib (SC-58635) Solubility in DMSO
- Celecoxib (SC-58635) Stock Solution
- Celecoxib (SC-58635) Storage
- Celecoxib (SC-58635) Stability
- Celecoxib (SC-58635) Combination Database
- Celecoxib (SC-58635) Molecular Weight
- Celecoxib (SC-58635) SMILES
- Celecoxib (SC-58635) CAS Number
- Celecoxib (SC-58635) Chemical Structure (2D and 3D)
- Celecoxib (SC-58635) IC50 for Cell-based and Cell-free Assays
- Celecoxib (SC-58635) APExBIO (A1664)? Try a better option.
- Celecoxib (SC-58635) Sigma (PHR1683)? Try a better option.
- Celecoxib (SC-58635) MedChemExpress (HY-14398)? Try a better option.
- Celecoxib (SC-58635) Cayman (10008672)? Try a better option.
- Celecoxib (SC-58635) SDS|MSDS